Trileptal
NDC 0078-0357, oxcarbazepine, suspension, from Novartis Pharmaceuticals Corporation.
- Product NDC
- 0078-0357
- Status
- Listed
- Labeler
- Novartis Pharmaceuticals Corporation
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021285
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0357 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXCARBAZEPINE60 mg/mL
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0078-0357-52 | 00078035752 | 250 mL in 1 BOTTLE (0078-0357-52) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/4c5c86c8-ab7f-4fcf-bc1b-5a0b1fd0691bNADAC price for package 00078035752
GET /v1/drugs/nadac/00078035752
Use it
Look up 0078-0357 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0357 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0078-0357. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.